Kiran Avancha

Kiran Avancha, PhD, currently serves as the Chief Innovation Officer at HonorHealth, responsible for developing innovation strategies and managing the organization’s innovation infrastructure. Kiran also holds the position of Chief Operating Officer at HonorHealth Research Institute and is the Co-Founder and CEO of PriZm Tx. Additional roles include serving on the Board of Directors for CenSyn, Inc. and as a Seed Investor in Chronus Health. Kiran co-founded ClinSync Clinical Research Pvt Ltd in India and previously worked as the Director of Cancer Clinical Research at Hartford HealthCare, overseeing oncology clinical research programs. Kiran's earlier experience includes roles at the University of Miami, Walgreens, Belcher Pharma, and Moffitt Cancer Center, focusing on clinical research and pharmacy. Kiran earned a Ph.D. in Medicinal/Pharmaceutical Chemistry from the University of South Florida and a B.Pharm from Osmania University.